Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200035/S038

OrganOx metra System

Organox Limited · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONP200035/S038

What did the FDA approve?

The FDA record for P200035/S038, dated 2026-10-09, lists a supplement to the OrganOx metra System PMA under the normal 180-day track, with the reason given as a change to design, components, specifications or materials. The reported changes cover a new supplier of the Blood Reservoir, minor manufacturing process changes for the filter materials, and increased wall thickness of five tubing segments in the blood circulation loop of Disposable Set D0146/D0146-US. The record does not quantify any of these changes or describe their verification.

The P200035 identifier ties this supplement to the existing PMA rather than to a separate approval, and the decision field reads APPR. The device category is described as a normothermic machine perfusion system for donor livers before transplantation. The supplied fields do not give test data, inspection findings or performance results, so the decision is a regulatory action on the described changes and not independent evidence of safety or clinical effectiveness.

The specific information absent is the basis for the decision beyond the listed change categories: no review memo, testing summary or closure rationale is included in these fields.

FDA approval order statement

changing the supplier of the Blood Reservoir, minor manufacturing process changes for the filter materials, and increasing the wall thickness of the five (5) tubing segments in the blood circulation loop of Disposable Set (D0146/D0146-US)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 9, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200035/S038
Regulatory pathway
PMA supplement
Product code
QQK
Decision code
APPR
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation.

Product code
QQK
FDA device class
3

For the original device and its historical approval scope, see PMA P200035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200035 · Original PMA

    OrganOx metra System

  2. P200035/S038 received

    Application receipt date recorded by FDA.

  3. P200035/S038 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P200035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200035

Product / regulatory recordCompanyPathwayDecision dateSource
Organox LimitedPMA approvalDec 9, 2021FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Organox Limited

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Oxford Science Park, Magdalen Centre, Robert Robinson Ave., Oxford, OX4 4GA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records